Bliss GVS Pharma gets EIR for Palghar manufacturing unit

15 Jun 2023 Evaluate

Bliss GVS Pharma has received the Establishment Inspection Report (EIR) for its manufacturing unit located at Dewan Udyog Nagar, Aliyali Village, Palghar, Maharashtra, indicating closure of the inspection through which the United States Food and Drug Administration (USFDA) agency assigned the inspection classification of the facility as ‘Voluntary Action Indicated (VAI)’.

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP). Earlier, USFDA had conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practices at the said manufacturing unit from March 13, 2023, to March 17, 2023.  

Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.


Bliss GVS Pharma Share Price

166.60 -9.20 (-5.23%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×